Correlation Between Edgewise Therapeutics and Acumen Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Acumen Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Acumen Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Acumen Pharmaceuticals, you can compare the effects of market volatilities on Edgewise Therapeutics and Acumen Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Acumen Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Acumen Pharmaceuticals.
Diversification Opportunities for Edgewise Therapeutics and Acumen Pharmaceuticals
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Edgewise and Acumen is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Acumen Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acumen Pharmaceuticals and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Acumen Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acumen Pharmaceuticals has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Acumen Pharmaceuticals go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Acumen Pharmaceuticals
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 0.45 times more return on investment than Acumen Pharmaceuticals. However, Edgewise Therapeutics is 2.21 times less risky than Acumen Pharmaceuticals. It trades about -0.14 of its potential returns per unit of risk. Acumen Pharmaceuticals is currently generating about -0.09 per unit of risk. If you would invest 3,481 in Edgewise Therapeutics on August 24, 2024 and sell it today you would lose (283.00) from holding Edgewise Therapeutics or give up 8.13% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Acumen Pharmaceuticals
Performance |
| Timeline |
| Edgewise Therapeutics |
| Acumen Pharmaceuticals |
Edgewise Therapeutics and Acumen Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Acumen Pharmaceuticals
The main advantage of trading using opposite Edgewise Therapeutics and Acumen Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Acumen Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acumen Pharmaceuticals will offset losses from the drop in Acumen Pharmaceuticals' long position.| Edgewise Therapeutics vs. Lyra Therapeutics | Edgewise Therapeutics vs. Hookipa Pharma | Edgewise Therapeutics vs. Cingulate Warrants | Edgewise Therapeutics vs. SAB Biotherapeutics |
| Acumen Pharmaceuticals vs. Terns Pharmaceuticals | Acumen Pharmaceuticals vs. X4 Pharmaceuticals | Acumen Pharmaceuticals vs. Day One Biopharmaceuticals | Acumen Pharmaceuticals vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Stocks Directory Find actively traded stocks across global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |